Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
BioAscent Discovery
BioAscent Discovery
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Finance
BioAscent reports increasing demand for compound management
Throughout the last two years the company has invested over £1m in its compound management infrastructure and grown its team by 40%
Finance
BioAscent appoints two Associate Directors
Dr Angelo Pugliese and Dr McArthur will be working as Associate Director of in silico discovery and data analysis, and Associate Director of medicinal chemistry respectively
Manufacturing
BioAscent Discovery names Director of Business Development for North America
Julian Abery joins the company as a consultant to expand the company in the US market
Regulatory
Dr Phil Jones to join BioAscent as new CSO
Research & Development
BioAscent appoints new CEO and plans to expand discovery services
Mental Health
Merz outsources its compound management to BioAscent
BioAscent supplies screening plates on demand to provide flexible and cost-effective management of solid and liquid compounds
Ingredients
BioAscent expands compound management services offering in collaboration with Pierre Fabre
Will become the central hub for storage and logistics of Pierre Fabre's plant natural extracts collection
Subscribe now